Search - tctmd.com

Displaying 201 - 215 of 215

Sort: Relevancy | Date

Presentation JIM 2017

Intravenous P2Y12 Receptor Inhibitors: Now We Can Do It

Presenter: Dominick J. Angiolillo

February 10, 2017

Presentation JIM 2017

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Presenter: Giuseppe Tarantini

February 10, 2017

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

Todd Neale

February 08, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

US Data Show Positive Trends in Cardiovascular Care, Though Opportunities for Progress Persist

Yael L. Maxwell

January 23, 2017

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Todd Neale

January 19, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation CCVVC 2016

Top 10 Advances of Interventional Cardiology 2015

Presenter: Samin K Sharma

June 16, 2016

Presentation CCVVC 2016

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

Presenter: Marc P. Bonaca

June 15, 2016

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Advertisement

Intravenous P2Y12 Receptor Inhibitors: Now We Can Do It

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

US Data Show Positive Trends in Cardiovascular Care, Though Opportunities for Progress Persist

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Timing of DAPT Interruption and DES Thrombosis

Top 10 Advances of Interventional Cardiology 2015

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Changing Course with Anticoagulation in Secondary Prevention of CAD

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content